Garder ma session ouverte ?
Expiré dans 
La session est expirée
Votre session a expiré. Pour votre sécurité, VWR vous a déconnecté.
Voulez-vous vous connecter à nouveau?

L'expérience en ligne d'Avantor évolue pour mieux vous accompagner ! À compter du 4 avril 2025, nos clients seront migrés vers une nouvelle plateforme pour une expérience d'achat en ligne simplifiée.

Votre recherche pour:

Sulphonazo III sodium salt


196  les résultats ont été trouvés

Upstream Gene Therapy Products & Solutions in Bioprocessing

Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...

Upstream Gene Therapy Products & Solutions in Bioprocessing

Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...

ls ge29064295 20131220222354

imagination at work Application note 29-0642-95 AA Chromatography systems Depletion of albumin from serum samples using ÄKTA™ start Albumin comprises 55% to 65% of the total protein in serum. The abundance of this protein makes it difficult to stu...

PDF

Solutions non stériles pour les surfaces et CIP

Solutions non stériles pour les surfaces et CIP L'offre de produits non stériles variant d'un pays à l'autre cette page offre une vue d'ensemble des gammes de produits disponibles. Notre équipe commerciale se fera un plaisir de vous renseigner sur...

Final fill for cell therapy

Final fill for cell therapy The cell therapy drug product is configured in different ways depending on the required delivery of the cells/tissues. For example delivery of chondrocytes for cartilage repair is administered by an injection. Expanded ...

Final fill for cell therapy

Final fill for cell therapy The cell therapy drug product is configured in different ways depending on the required delivery of the cells/tissues. For example delivery of chondrocytes for cartilage repair is administered by an injection. Expanded ...

ls ge29064295 20131220222354

imagination at work Application note 29-0642-95 AA Chromatography systems Depletion of albumin from serum samples using ÄKTA™ start Albumin comprises 55% to 65% of the total protein in serum. The abundance of this protein makes it difficult to stu...

PDF

15 produits chimiques de laboratoire courants et comment les organiser

15 produits chimiques de laboratoire courants et comment les organiser Pour faire fonctionner correctement un laboratoire vous devez sélectionner les produits chimiques appropriés afin de mettre en œuvre des procédures sûres et efficaces. En fonct...

Aurora Manufacturing Facility

Aurora Manufacturing Facility Core Capabilities Supply of excipients down-packed in controlled and segregated environments to meet analytical and biological requirements Custom finished goods packaging configurations including OEM packaging and la...

Downstream purification for recombinant proteins

Downstream purification for recombinant proteins With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used s...

Downstream purification for recombinant proteins

Downstream purification for recombinant proteins With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used s...

Final fill for vaccines

Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...

Final fill for mAbs

Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...

Final fill for mAbs

Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...

Upstream processing for cell therapy

Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...

Final fill for vaccines

Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...

97 - 112 of 196

Ce site utilise des cookies, en provenance de VWR ou de ses partenaires, afin de collecter des informations statistiques sur votre navigation et vous proposer des contenus en accord avec vos préférences, générés en fonction de vos habitudes de navigation. En poursuivant la consultation de ce site, vous approuvez l’utilisation de ces cookies.

Pour en savoir plus, consultez notre Politique de Confidentialité..